LENNHAM PHARMACEUTICALS

Lennham Pharmaceuticals is dedicated to improving the metabolic and pharmacological profile of drugs through deuterium chemistry. The companies approach has yielded significantly improved products with strong patent protection by identifying chemical compounds that could benefit from a modification to their metabolic or pharmacokinetic properties, generating experimental data to determine if deuterium chemistry can influence one or more metabolic or pharmacokinetic properties and support broad patent protection, and advancing products with a high probability of clinical success and significant commercial potential.